Global Journal of Oncology Drug Development and Care (GJODDC) is an international, open-access, peer-reviewed journal dedicated to advancing innovation and excellence in oncology drug development, pharmaceutical care, and clinical application. Published by JAG Unified International, GJODDC serves as a dynamic scholarly forum that integrates research, practice, and policy to improve cancer treatment outcomes worldwide.
Our journal aims to bridge the gap between discovery science and clinical implementation by publishing high-impact research that addresses challenges in developing and delivering effective cancer therapies. With a strong commitment to scientific rigor, ethical publication, and global accessibility, GJODDC provides a voice for oncologists, pharmacists, scientists, and healthcare professionals committed to improving lives through better drug solutions in oncology.
Our Mission
To promote the dissemination of novel, evidence-based research and foster collaboration across disciplines engaged in oncology drug development and patient care.
Our Vision
To be a globally recognized platform that drives forward the boundaries of oncology therapeutics through innovation, quality, and patient-centered care.
Journal Highlights
- Publishes original research, systematic reviews, case studies, and clinical reports
- Covers drug discovery, formulation, pharmacology, clinical trials, and supportive care
- Encourages translational studies that impact real-world oncology practice
- Follows ethical publishing standards recommended by COPE and ICMJE
Who Should Read GJODDC?
- Oncology researchers and pharmaceutical scientists
- Clinical oncologists and oncology pharmacists
- Biotech innovators and regulatory professionals
- Academicians, students, and policy stakeholders in cancer therapeutics
We welcome your contributions and collaboration in shaping the future of cancer drug development and care.
